Trigon International Corporation has been sold to Precision Engineered Products
Lincoln International (“Lincoln”), a leading global mid-market investment bank, has announced that Trigon International Corporation (“Trigon” or the “Company”) has been sold to Precision Engineered Products LLC (“PEP”), a portfolio company of The Jordan Company and Nautic Partners.
Headquartered in Aurora, Illinois, with an additional operation in Warsaw, Indiana, Trigon is a leading provider of instruments and implants for the orthopedic market. The Company offers a full suite of design, engineering, manufacturing and assembly services to OEMs for complex orthopedic applications across segments including knees, hips, extremities, trauma and spine. Through its acquisition of Trigon, PEP, a leading manufacturer of medical devices and components, further increases its share in the orthopedic market.
“We, at Trigon, are truly excited about this new partnership with PEP which will enable us to offer more capabilities to our existing customer base, including sterile barrier packaging, precision stamping and plastic molding,” said Joe Fenoglio, President and CEO of Trigon. “In this ever-changing industry, it is critical that we be able to quickly respond to the customer with a full range of precision-engineered solutions. With this new partnership, our ability to respond to that need will be second to none.”
“The combination of Trigon International with our capabilities in orthopedic surgical device design, prototyping, package design and validation services will provide customers with a full suite of services for orthopedic products,” said John Manzi, President and CEO of PEP. “Trigon International enhances PEP’s ability to meet the stringent regulatory requirements for the orthopedic market, and its position in the marketplace will drive continued customer growth with orthopedic and medical OEMs.”
Lincoln acted as the exclusive financial advisor to Trigon, working closely with the Company’s owners and management team throughout the sale process. This included providing advisory expertise and managing the preparatory, marketing, negotiation and due diligence phases of the transaction.
Meet Our Professionals
View More Transactions
Lincoln International is pleased to announce the successful sale of C³ (Cannabinoid Compound Company), a subsidiary of Bionorica SE, a producer and marketer of cannabis-based therapeutic compounds, to Canopy Growth
Lincoln is pleased to announce that it has advised Riello Investimenti SGR on the sale of Trafimet Group to Kemppi Oy
Lincoln International is pleased to have advised Tikehau Capital on its £23 million minority investment into Medtrade, a UK based manufacturer of advanced woundcare and consumer healthcare products
Lincoln International is pleased to announce the successful completion of a $20 million Series C financing round for Rapid Medical